Comparison of Sevoflurane and Propofol on ANI

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorPusan National University Yangsan Hospital

About this trial

The goal of this clinical trial is to compare the effect of sevoflurane and propofol on analgesia nociception index(ANI) in patients undergoing general anesthesia. The main question it aims to answer is whether propofol anesthesia results in lesser ANI change to a nociceptive stimulation compared to sevoflurane.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

American society of anesthesiologists physical status class I or II

Disqualifiers

history of drugs that can affect the central nervous system and autonomic nervous system, such as anticholinergics, betablockers, antidepressants..etc.

history of allergic reaction to sevoflurane and/or propofol

history of and/or family history of malignant hyperthermia

neurodegenerative disorder

Trial design

Design model

Parallel

Treatments tested in this trial

  • propofol

    Drug

    propofol anesthesia

  • Sevoflurane

    Drug

    sevoflurane anesthesia

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: SevofluraneOther 1 intervention
Group B: PropofolOther 1 intervention

Trial outcomes

Primary outcomes

1

analgesia nociception index change

analgesia nociception index value 1-minute before tetanic stimulation and 1-minute after tetanic stimulation

Time frame
During anesthesia period

Secondary outcomes

1

Hemodynamic change

Blood pressure change 1 minute before tetanic stimuation and 1 minute after tetanic stimulation

Time frame
During anesthesia period
2

Hemodynamic change

Heart rate change before 1-minute before nociceptive stimuli and 1-minute after nociceptive stimuli

Time frame
During anesthesia period

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: